nodes	percent_of_prediction	percent_of_DWPC	metapath
Conjugated Estrogens—ABCB1—peripheral nervous system neoplasm	0.182	1	CbGaD
Conjugated Estrogens—ABCC3—Vincristine—peripheral nervous system neoplasm	0.0401	0.0698	CbGbCtD
Conjugated Estrogens—ABCC1—Dactinomycin—peripheral nervous system neoplasm	0.0399	0.0696	CbGbCtD
Conjugated Estrogens—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0386	0.0672	CbGbCtD
Conjugated Estrogens—ABCC3—Cisplatin—peripheral nervous system neoplasm	0.0374	0.0651	CbGbCtD
Conjugated Estrogens—ABCC3—Etoposide—peripheral nervous system neoplasm	0.0367	0.0639	CbGbCtD
Conjugated Estrogens—ABCC1—Epirubicin—peripheral nervous system neoplasm	0.0289	0.0504	CbGbCtD
Conjugated Estrogens—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0267	0.0466	CbGbCtD
Conjugated Estrogens—ABCC3—Doxorubicin—peripheral nervous system neoplasm	0.025	0.0436	CbGbCtD
Conjugated Estrogens—ABCC1—Vincristine—peripheral nervous system neoplasm	0.0246	0.0428	CbGbCtD
Conjugated Estrogens—ABCC1—Etoposide—peripheral nervous system neoplasm	0.0225	0.0393	CbGbCtD
Conjugated Estrogens—ABCC2—Vincristine—peripheral nervous system neoplasm	0.0182	0.0317	CbGbCtD
Conjugated Estrogens—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.017	0.0296	CbGbCtD
Conjugated Estrogens—ABCC2—Etoposide—peripheral nervous system neoplasm	0.0167	0.0291	CbGbCtD
Conjugated Estrogens—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0165	0.0287	CbGbCtD
Conjugated Estrogens—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0159	0.0277	CbGbCtD
Conjugated Estrogens—ABCC1—Doxorubicin—peripheral nervous system neoplasm	0.0154	0.0268	CbGbCtD
Conjugated Estrogens—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0153	0.0267	CbGbCtD
Conjugated Estrogens—ABCG2—Etoposide—peripheral nervous system neoplasm	0.0151	0.0263	CbGbCtD
Conjugated Estrogens—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0139	0.0242	CbGbCtD
Conjugated Estrogens—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0139	0.0242	CbGbCtD
Conjugated Estrogens—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0127	0.0221	CbGbCtD
Conjugated Estrogens—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.0114	0.0198	CbGbCtD
Conjugated Estrogens—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.0103	0.0179	CbGbCtD
Conjugated Estrogens—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.00964	0.0168	CbGbCtD
Conjugated Estrogens—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.00833	0.0145	CbGbCtD
Conjugated Estrogens—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00774	0.0135	CbGbCtD
Conjugated Estrogens—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.00622	0.0108	CbGbCtD
Conjugated Estrogens—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00593	0.0103	CbGbCtD
Conjugated Estrogens—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00553	0.00964	CbGbCtD
Conjugated Estrogens—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00544	0.00947	CbGbCtD
Conjugated Estrogens—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00371	0.00646	CbGbCtD
Conjugated Estrogens—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00356	0.00619	CbGbCtD
Conjugated Estrogens—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00326	0.00568	CbGbCtD
Conjugated Estrogens—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00222	0.00387	CbGbCtD
Conjugated Estrogens—Estriol—ABCB1—peripheral nervous system neoplasm	0.000374	0.302	CrCbGaD
Conjugated Estrogens—Estramustine—ABCB1—peripheral nervous system neoplasm	0.000348	0.281	CrCbGaD
Conjugated Estrogens—Ethinyl Estradiol—ABCB1—peripheral nervous system neoplasm	0.000205	0.165	CrCbGaD
Conjugated Estrogens—Estrone—ABCB1—peripheral nervous system neoplasm	0.000178	0.144	CrCbGaD
Conjugated Estrogens—Estradiol—ABCB1—peripheral nervous system neoplasm	0.000135	0.109	CrCbGaD
Conjugated Estrogens—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	9.15e-05	0.00048	CcSEcCtD
Conjugated Estrogens—Nausea—Topotecan—peripheral nervous system neoplasm	9.14e-05	0.00048	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	9.12e-05	0.000479	CcSEcCtD
Conjugated Estrogens—Nausea—Tretinoin—peripheral nervous system neoplasm	9.07e-05	0.000476	CcSEcCtD
Conjugated Estrogens—Nausea—Isotretinoin—peripheral nervous system neoplasm	9.07e-05	0.000476	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	9.03e-05	0.000474	CcSEcCtD
Conjugated Estrogens—Mood swings—Doxorubicin—peripheral nervous system neoplasm	9.03e-05	0.000474	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	8.98e-05	0.000472	CcSEcCtD
Conjugated Estrogens—Infection—Etoposide—peripheral nervous system neoplasm	8.97e-05	0.000471	CcSEcCtD
Conjugated Estrogens—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	8.96e-05	0.000471	CcSEcCtD
Conjugated Estrogens—Asthenia—Dactinomycin—peripheral nervous system neoplasm	8.95e-05	0.00047	CcSEcCtD
Conjugated Estrogens—Nausea—Melphalan—peripheral nervous system neoplasm	8.95e-05	0.00047	CcSEcCtD
Conjugated Estrogens—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	8.93e-05	0.000469	CcSEcCtD
Conjugated Estrogens—Asthma—Epirubicin—peripheral nervous system neoplasm	8.9e-05	0.000467	CcSEcCtD
Conjugated Estrogens—Influenza—Epirubicin—peripheral nervous system neoplasm	8.9e-05	0.000467	CcSEcCtD
Conjugated Estrogens—Dysphagia—Epirubicin—peripheral nervous system neoplasm	8.9e-05	0.000467	CcSEcCtD
Conjugated Estrogens—Dehydration—Doxorubicin—peripheral nervous system neoplasm	8.86e-05	0.000465	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	8.85e-05	0.000465	CcSEcCtD
Conjugated Estrogens—Tachycardia—Etoposide—peripheral nervous system neoplasm	8.81e-05	0.000463	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Vincristine—peripheral nervous system neoplasm	8.81e-05	0.000463	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Vincristine—peripheral nervous system neoplasm	8.81e-05	0.000463	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	8.79e-05	0.000462	CcSEcCtD
Conjugated Estrogens—Skin disorder—Etoposide—peripheral nervous system neoplasm	8.77e-05	0.000461	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	8.73e-05	0.000458	CcSEcCtD
Conjugated Estrogens—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	8.73e-05	0.000458	CcSEcCtD
Conjugated Estrogens—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	8.67e-05	0.000455	CcSEcCtD
Conjugated Estrogens—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	8.61e-05	0.000452	CcSEcCtD
Conjugated Estrogens—Anorexia—Etoposide—peripheral nervous system neoplasm	8.61e-05	0.000452	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	8.57e-05	0.00045	CcSEcCtD
Conjugated Estrogens—Bronchitis—Epirubicin—peripheral nervous system neoplasm	8.56e-05	0.00045	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	8.54e-05	0.000448	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	8.52e-05	0.000448	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	8.51e-05	0.000447	CcSEcCtD
Conjugated Estrogens—Hypotension—Etoposide—peripheral nervous system neoplasm	8.44e-05	0.000443	CcSEcCtD
Conjugated Estrogens—Pain—Cisplatin—peripheral nervous system neoplasm	8.43e-05	0.000443	CcSEcCtD
Conjugated Estrogens—Dysuria—Epirubicin—peripheral nervous system neoplasm	8.33e-05	0.000437	CcSEcCtD
Conjugated Estrogens—Asthenia—Alitretinoin—peripheral nervous system neoplasm	8.3e-05	0.000436	CcSEcCtD
Conjugated Estrogens—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	8.29e-05	0.000435	CcSEcCtD
Conjugated Estrogens—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	8.27e-05	0.000434	CcSEcCtD
Conjugated Estrogens—Asthma—Doxorubicin—peripheral nervous system neoplasm	8.24e-05	0.000433	CcSEcCtD
Conjugated Estrogens—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	8.24e-05	0.000433	CcSEcCtD
Conjugated Estrogens—Influenza—Doxorubicin—peripheral nervous system neoplasm	8.24e-05	0.000433	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	8.21e-05	0.000431	CcSEcCtD
Conjugated Estrogens—Pruritus—Alitretinoin—peripheral nervous system neoplasm	8.19e-05	0.00043	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Etoposide—peripheral nervous system neoplasm	8.11e-05	0.000426	CcSEcCtD
Conjugated Estrogens—Weight increased—Epirubicin—peripheral nervous system neoplasm	8.1e-05	0.000425	CcSEcCtD
Conjugated Estrogens—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	8.08e-05	0.000424	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Etoposide—peripheral nervous system neoplasm	8.05e-05	0.000423	CcSEcCtD
Conjugated Estrogens—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	8.03e-05	0.000422	CcSEcCtD
Conjugated Estrogens—Somnolence—Etoposide—peripheral nervous system neoplasm	8.03e-05	0.000422	CcSEcCtD
Conjugated Estrogens—Asthenia—Vincristine—peripheral nervous system neoplasm	8e-05	0.00042	CcSEcCtD
Conjugated Estrogens—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	7.94e-05	0.000417	CcSEcCtD
Conjugated Estrogens—Infestation—Epirubicin—peripheral nervous system neoplasm	7.94e-05	0.000417	CcSEcCtD
Conjugated Estrogens—Vomiting—Dactinomycin—peripheral nervous system neoplasm	7.93e-05	0.000417	CcSEcCtD
Conjugated Estrogens—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	7.92e-05	0.000416	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	7.92e-05	0.000416	CcSEcCtD
Conjugated Estrogens—Rash—Dactinomycin—peripheral nervous system neoplasm	7.87e-05	0.000413	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Etoposide—peripheral nervous system neoplasm	7.85e-05	0.000412	CcSEcCtD
Conjugated Estrogens—Renal failure—Epirubicin—peripheral nervous system neoplasm	7.8e-05	0.00041	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	7.8e-05	0.000409	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	7.79e-05	0.000409	CcSEcCtD
Conjugated Estrogens—Fatigue—Etoposide—peripheral nervous system neoplasm	7.79e-05	0.000409	CcSEcCtD
Conjugated Estrogens—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	7.78e-05	0.000409	CcSEcCtD
Conjugated Estrogens—Pain—Etoposide—peripheral nervous system neoplasm	7.72e-05	0.000406	CcSEcCtD
Conjugated Estrogens—Constipation—Etoposide—peripheral nervous system neoplasm	7.72e-05	0.000406	CcSEcCtD
Conjugated Estrogens—Dysuria—Doxorubicin—peripheral nervous system neoplasm	7.7e-05	0.000404	CcSEcCtD
Conjugated Estrogens—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	7.66e-05	0.000402	CcSEcCtD
Conjugated Estrogens—Dizziness—Alitretinoin—peripheral nervous system neoplasm	7.65e-05	0.000402	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Vincristine—peripheral nervous system neoplasm	7.63e-05	0.000401	CcSEcCtD
Conjugated Estrogens—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	7.51e-05	0.000394	CcSEcCtD
Conjugated Estrogens—Weight increased—Doxorubicin—peripheral nervous system neoplasm	7.5e-05	0.000394	CcSEcCtD
Conjugated Estrogens—Sinusitis—Epirubicin—peripheral nervous system neoplasm	7.45e-05	0.000391	CcSEcCtD
Conjugated Estrogens—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	7.43e-05	0.00039	CcSEcCtD
Conjugated Estrogens—Nausea—Dactinomycin—peripheral nervous system neoplasm	7.41e-05	0.000389	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	7.39e-05	0.000388	CcSEcCtD
Conjugated Estrogens—Dizziness—Vincristine—peripheral nervous system neoplasm	7.37e-05	0.000387	CcSEcCtD
Conjugated Estrogens—Vomiting—Alitretinoin—peripheral nervous system neoplasm	7.36e-05	0.000386	CcSEcCtD
Conjugated Estrogens—Infestation—Doxorubicin—peripheral nervous system neoplasm	7.34e-05	0.000386	CcSEcCtD
Conjugated Estrogens—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	7.34e-05	0.000386	CcSEcCtD
Conjugated Estrogens—Rash—Alitretinoin—peripheral nervous system neoplasm	7.3e-05	0.000383	CcSEcCtD
Conjugated Estrogens—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	7.29e-05	0.000383	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	7.26e-05	0.000381	CcSEcCtD
Conjugated Estrogens—Headache—Alitretinoin—peripheral nervous system neoplasm	7.25e-05	0.000381	CcSEcCtD
Conjugated Estrogens—Renal failure—Doxorubicin—peripheral nervous system neoplasm	7.22e-05	0.000379	CcSEcCtD
Conjugated Estrogens—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	7.2e-05	0.000378	CcSEcCtD
Conjugated Estrogens—Urticaria—Etoposide—peripheral nervous system neoplasm	7.18e-05	0.000377	CcSEcCtD
Conjugated Estrogens—Rhinitis—Epirubicin—peripheral nervous system neoplasm	7.14e-05	0.000375	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Etoposide—peripheral nervous system neoplasm	7.14e-05	0.000375	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Etoposide—peripheral nervous system neoplasm	7.14e-05	0.000375	CcSEcCtD
Conjugated Estrogens—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	7.09e-05	0.000372	CcSEcCtD
Conjugated Estrogens—Vomiting—Vincristine—peripheral nervous system neoplasm	7.09e-05	0.000372	CcSEcCtD
Conjugated Estrogens—Asthenia—Cisplatin—peripheral nervous system neoplasm	7.07e-05	0.000371	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	7.07e-05	0.000371	CcSEcCtD
Conjugated Estrogens—Rash—Vincristine—peripheral nervous system neoplasm	7.03e-05	0.000369	CcSEcCtD
Conjugated Estrogens—Dermatitis—Vincristine—peripheral nervous system neoplasm	7.02e-05	0.000369	CcSEcCtD
Conjugated Estrogens—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	7.02e-05	0.000369	CcSEcCtD
Conjugated Estrogens—Headache—Vincristine—peripheral nervous system neoplasm	6.98e-05	0.000367	CcSEcCtD
Conjugated Estrogens—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	6.95e-05	0.000365	CcSEcCtD
Conjugated Estrogens—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	6.89e-05	0.000362	CcSEcCtD
Conjugated Estrogens—Nausea—Alitretinoin—peripheral nervous system neoplasm	6.87e-05	0.000361	CcSEcCtD
Conjugated Estrogens—Visual impairment—Epirubicin—peripheral nervous system neoplasm	6.87e-05	0.000361	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	6.75e-05	0.000354	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	6.74e-05	0.000354	CcSEcCtD
Conjugated Estrogens—Eye disorder—Epirubicin—peripheral nervous system neoplasm	6.66e-05	0.00035	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	6.65e-05	0.000349	CcSEcCtD
Conjugated Estrogens—Nausea—Vincristine—peripheral nervous system neoplasm	6.62e-05	0.000348	CcSEcCtD
Conjugated Estrogens—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	6.61e-05	0.000347	CcSEcCtD
Conjugated Estrogens—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	6.61e-05	0.000347	CcSEcCtD
Conjugated Estrogens—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	6.56e-05	0.000344	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	6.54e-05	0.000344	CcSEcCtD
Conjugated Estrogens—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	6.5e-05	0.000341	CcSEcCtD
Conjugated Estrogens—Asthenia—Etoposide—peripheral nervous system neoplasm	6.48e-05	0.00034	CcSEcCtD
Conjugated Estrogens—Angiopathy—Epirubicin—peripheral nervous system neoplasm	6.47e-05	0.000339	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	6.44e-05	0.000338	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	6.42e-05	0.000337	CcSEcCtD
Conjugated Estrogens—Pruritus—Etoposide—peripheral nervous system neoplasm	6.39e-05	0.000336	CcSEcCtD
Conjugated Estrogens—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	6.37e-05	0.000334	CcSEcCtD
Conjugated Estrogens—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	6.35e-05	0.000334	CcSEcCtD
Conjugated Estrogens—Alopecia—Epirubicin—peripheral nervous system neoplasm	6.3e-05	0.000331	CcSEcCtD
Conjugated Estrogens—Vomiting—Cisplatin—peripheral nervous system neoplasm	6.27e-05	0.000329	CcSEcCtD
Conjugated Estrogens—Mental disorder—Epirubicin—peripheral nervous system neoplasm	6.24e-05	0.000328	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	6.23e-05	0.000327	CcSEcCtD
Conjugated Estrogens—Rash—Cisplatin—peripheral nervous system neoplasm	6.22e-05	0.000326	CcSEcCtD
Conjugated Estrogens—Dermatitis—Cisplatin—peripheral nervous system neoplasm	6.21e-05	0.000326	CcSEcCtD
Conjugated Estrogens—Erythema—Epirubicin—peripheral nervous system neoplasm	6.2e-05	0.000326	CcSEcCtD
Conjugated Estrogens—Malnutrition—Epirubicin—peripheral nervous system neoplasm	6.2e-05	0.000326	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Etoposide—peripheral nervous system neoplasm	6.18e-05	0.000324	CcSEcCtD
Conjugated Estrogens—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	6.16e-05	0.000324	CcSEcCtD
Conjugated Estrogens—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	6.12e-05	0.000321	CcSEcCtD
Conjugated Estrogens—Flatulence—Epirubicin—peripheral nervous system neoplasm	6.11e-05	0.000321	CcSEcCtD
Conjugated Estrogens—Tension—Epirubicin—peripheral nervous system neoplasm	6.09e-05	0.00032	CcSEcCtD
Conjugated Estrogens—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	6.07e-05	0.000319	CcSEcCtD
Conjugated Estrogens—Nervousness—Epirubicin—peripheral nervous system neoplasm	6.03e-05	0.000316	CcSEcCtD
Conjugated Estrogens—Back pain—Epirubicin—peripheral nervous system neoplasm	6e-05	0.000315	CcSEcCtD
Conjugated Estrogens—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	5.98e-05	0.000314	CcSEcCtD
Conjugated Estrogens—Dizziness—Etoposide—peripheral nervous system neoplasm	5.97e-05	0.000314	CcSEcCtD
Conjugated Estrogens—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	5.96e-05	0.000313	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	5.96e-05	0.000313	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	5.94e-05	0.000312	CcSEcCtD
Conjugated Estrogens—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	5.89e-05	0.000309	CcSEcCtD
Conjugated Estrogens—Nausea—Cisplatin—peripheral nervous system neoplasm	5.86e-05	0.000307	CcSEcCtD
Conjugated Estrogens—Vision blurred—Epirubicin—peripheral nervous system neoplasm	5.85e-05	0.000307	CcSEcCtD
Conjugated Estrogens—Alopecia—Doxorubicin—peripheral nervous system neoplasm	5.83e-05	0.000306	CcSEcCtD
Conjugated Estrogens—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	5.78e-05	0.000303	CcSEcCtD
Conjugated Estrogens—Vomiting—Etoposide—peripheral nervous system neoplasm	5.74e-05	0.000302	CcSEcCtD
Conjugated Estrogens—Erythema—Doxorubicin—peripheral nervous system neoplasm	5.74e-05	0.000301	CcSEcCtD
Conjugated Estrogens—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	5.74e-05	0.000301	CcSEcCtD
Conjugated Estrogens—ESR1—Plasma membrane estrogen receptor signaling—AKT1—peripheral nervous system neoplasm	5.7e-05	0.00108	CbGpPWpGaD
Conjugated Estrogens—Rash—Etoposide—peripheral nervous system neoplasm	5.69e-05	0.000299	CcSEcCtD
Conjugated Estrogens—Dermatitis—Etoposide—peripheral nervous system neoplasm	5.69e-05	0.000299	CcSEcCtD
Conjugated Estrogens—Headache—Etoposide—peripheral nervous system neoplasm	5.66e-05	0.000297	CcSEcCtD
Conjugated Estrogens—Flatulence—Doxorubicin—peripheral nervous system neoplasm	5.66e-05	0.000297	CcSEcCtD
Conjugated Estrogens—Tension—Doxorubicin—peripheral nervous system neoplasm	5.63e-05	0.000296	CcSEcCtD
Conjugated Estrogens—ABCG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.62e-05	0.00107	CbGpPWpGaD
Conjugated Estrogens—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	5.62e-05	0.000295	CcSEcCtD
Conjugated Estrogens—COMT—Metabolism—GNS—peripheral nervous system neoplasm	5.62e-05	0.00107	CbGpPWpGaD
Conjugated Estrogens—Nervousness—Doxorubicin—peripheral nervous system neoplasm	5.57e-05	0.000293	CcSEcCtD
Conjugated Estrogens—Vertigo—Epirubicin—peripheral nervous system neoplasm	5.57e-05	0.000293	CcSEcCtD
Conjugated Estrogens—Syncope—Epirubicin—peripheral nervous system neoplasm	5.56e-05	0.000292	CcSEcCtD
Conjugated Estrogens—Back pain—Doxorubicin—peripheral nervous system neoplasm	5.55e-05	0.000292	CcSEcCtD
Conjugated Estrogens—SLC22A11—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.55e-05	0.00106	CbGpPWpGaD
Conjugated Estrogens—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	5.52e-05	0.00029	CcSEcCtD
Conjugated Estrogens—Palpitations—Epirubicin—peripheral nervous system neoplasm	5.48e-05	0.000288	CcSEcCtD
Conjugated Estrogens—ESR1—Regulation of Telomerase—MYC—peripheral nervous system neoplasm	5.48e-05	0.00104	CbGpPWpGaD
Conjugated Estrogens—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	5.45e-05	0.000286	CcSEcCtD
Conjugated Estrogens—Cough—Epirubicin—peripheral nervous system neoplasm	5.41e-05	0.000284	CcSEcCtD
Conjugated Estrogens—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	5.41e-05	0.000284	CcSEcCtD
Conjugated Estrogens—COMT—Metabolism—NME1—peripheral nervous system neoplasm	5.38e-05	0.00102	CbGpPWpGaD
Conjugated Estrogens—Convulsion—Epirubicin—peripheral nervous system neoplasm	5.37e-05	0.000282	CcSEcCtD
Conjugated Estrogens—Nausea—Etoposide—peripheral nervous system neoplasm	5.36e-05	0.000282	CcSEcCtD
Conjugated Estrogens—ESR1—AP-1 transcription factor network—MYC—peripheral nervous system neoplasm	5.35e-05	0.00102	CbGpPWpGaD
Conjugated Estrogens—Chest pain—Epirubicin—peripheral nervous system neoplasm	5.28e-05	0.000277	CcSEcCtD
Conjugated Estrogens—Arthralgia—Epirubicin—peripheral nervous system neoplasm	5.28e-05	0.000277	CcSEcCtD
Conjugated Estrogens—Myalgia—Epirubicin—peripheral nervous system neoplasm	5.28e-05	0.000277	CcSEcCtD
Conjugated Estrogens—SLCO1B3—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	5.27e-05	0.001	CbGpPWpGaD
Conjugated Estrogens—Anxiety—Epirubicin—peripheral nervous system neoplasm	5.26e-05	0.000276	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	5.24e-05	0.000275	CcSEcCtD
Conjugated Estrogens—ESR1—Gene Expression—EED—peripheral nervous system neoplasm	5.19e-05	0.000988	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—COX2—peripheral nervous system neoplasm	5.18e-05	0.000986	CbGpPWpGaD
Conjugated Estrogens—Vertigo—Doxorubicin—peripheral nervous system neoplasm	5.16e-05	0.000271	CcSEcCtD
Conjugated Estrogens—Syncope—Doxorubicin—peripheral nervous system neoplasm	5.15e-05	0.00027	CcSEcCtD
Conjugated Estrogens—ESR1—Signaling by ERBB4—PTPN11—peripheral nervous system neoplasm	5.14e-05	0.000979	CbGpPWpGaD
Conjugated Estrogens—Palpitations—Doxorubicin—peripheral nervous system neoplasm	5.07e-05	0.000266	CcSEcCtD
Conjugated Estrogens—Oedema—Epirubicin—peripheral nervous system neoplasm	5.06e-05	0.000266	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	5.06e-05	0.000266	CcSEcCtD
Conjugated Estrogens—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	5.04e-05	0.000265	CcSEcCtD
Conjugated Estrogens—Infection—Epirubicin—peripheral nervous system neoplasm	5.03e-05	0.000264	CcSEcCtD
Conjugated Estrogens—Cough—Doxorubicin—peripheral nervous system neoplasm	5.01e-05	0.000263	CcSEcCtD
Conjugated Estrogens—SLCO1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.99e-05	0.000949	CbGpPWpGaD
Conjugated Estrogens—Shock—Epirubicin—peripheral nervous system neoplasm	4.98e-05	0.000262	CcSEcCtD
Conjugated Estrogens—Convulsion—Doxorubicin—peripheral nervous system neoplasm	4.97e-05	0.000261	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	4.97e-05	0.000261	CcSEcCtD
Conjugated Estrogens—Tachycardia—Epirubicin—peripheral nervous system neoplasm	4.94e-05	0.000259	CcSEcCtD
Conjugated Estrogens—SLCO2B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.93e-05	0.000938	CbGpPWpGaD
Conjugated Estrogens—Skin disorder—Epirubicin—peripheral nervous system neoplasm	4.92e-05	0.000258	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	4.89e-05	0.000257	CcSEcCtD
Conjugated Estrogens—Chest pain—Doxorubicin—peripheral nervous system neoplasm	4.89e-05	0.000257	CcSEcCtD
Conjugated Estrogens—Myalgia—Doxorubicin—peripheral nervous system neoplasm	4.89e-05	0.000257	CcSEcCtD
Conjugated Estrogens—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	4.89e-05	0.000257	CcSEcCtD
Conjugated Estrogens—Anxiety—Doxorubicin—peripheral nervous system neoplasm	4.87e-05	0.000256	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	4.85e-05	0.000255	CcSEcCtD
Conjugated Estrogens—SLCO2B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.84e-05	0.000921	CbGpPWpGaD
Conjugated Estrogens—Anorexia—Epirubicin—peripheral nervous system neoplasm	4.83e-05	0.000253	CcSEcCtD
Conjugated Estrogens—SLCO1B3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.78e-05	0.000911	CbGpPWpGaD
Conjugated Estrogens—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—peripheral nervous system neoplasm	4.76e-05	0.000907	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.76e-05	0.000906	CbGpPWpGaD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	4.76e-05	0.000905	CbGpPWpGaD
Conjugated Estrogens—Hypotension—Epirubicin—peripheral nervous system neoplasm	4.73e-05	0.000248	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	4.68e-05	0.000246	CcSEcCtD
Conjugated Estrogens—Oedema—Doxorubicin—peripheral nervous system neoplasm	4.68e-05	0.000246	CcSEcCtD
Conjugated Estrogens—ABCC4—Hemostasis—IFNB1—peripheral nervous system neoplasm	4.65e-05	0.000886	CbGpPWpGaD
Conjugated Estrogens—Infection—Doxorubicin—peripheral nervous system neoplasm	4.65e-05	0.000244	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	4.61e-05	0.000242	CcSEcCtD
Conjugated Estrogens—Shock—Doxorubicin—peripheral nervous system neoplasm	4.61e-05	0.000242	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	4.59e-05	0.000241	CcSEcCtD
Conjugated Estrogens—SLCO1B3—Metabolism—GNS—peripheral nervous system neoplasm	4.59e-05	0.000873	CbGpPWpGaD
Conjugated Estrogens—Insomnia—Epirubicin—peripheral nervous system neoplasm	4.58e-05	0.00024	CcSEcCtD
Conjugated Estrogens—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	4.57e-05	0.00024	CcSEcCtD
Conjugated Estrogens—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	4.55e-05	0.000239	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	4.55e-05	0.000239	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	4.53e-05	0.000238	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	4.51e-05	0.000237	CcSEcCtD
Conjugated Estrogens—Somnolence—Epirubicin—peripheral nervous system neoplasm	4.5e-05	0.000236	CcSEcCtD
Conjugated Estrogens—ABCC1—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.49e-05	0.000854	CbGpPWpGaD
Conjugated Estrogens—SLC22A11—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.47e-05	0.00085	CbGpPWpGaD
Conjugated Estrogens—Anorexia—Doxorubicin—peripheral nervous system neoplasm	4.47e-05	0.000234	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	4.46e-05	0.000234	CcSEcCtD
Conjugated Estrogens—SLC10A1—Metabolism—ENO2—peripheral nervous system neoplasm	4.44e-05	0.000845	CbGpPWpGaD
Conjugated Estrogens—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	4.4e-05	0.000231	CcSEcCtD
Conjugated Estrogens—SLCO1B3—Metabolism—NME1—peripheral nervous system neoplasm	4.4e-05	0.000837	CbGpPWpGaD
Conjugated Estrogens—ESR1—AP-1 transcription factor network—TP53—peripheral nervous system neoplasm	4.4e-05	0.000837	CbGpPWpGaD
Conjugated Estrogens—SLC22A11—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.38e-05	0.000834	CbGpPWpGaD
Conjugated Estrogens—Hypotension—Doxorubicin—peripheral nervous system neoplasm	4.38e-05	0.00023	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	4.37e-05	0.00023	CcSEcCtD
Conjugated Estrogens—Fatigue—Epirubicin—peripheral nervous system neoplasm	4.36e-05	0.000229	CcSEcCtD
Conjugated Estrogens—Pain—Epirubicin—peripheral nervous system neoplasm	4.33e-05	0.000227	CcSEcCtD
Conjugated Estrogens—Constipation—Epirubicin—peripheral nervous system neoplasm	4.33e-05	0.000227	CcSEcCtD
Conjugated Estrogens—ABCC3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.32e-05	0.000822	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—KNG1—peripheral nervous system neoplasm	4.31e-05	0.000821	CbGpPWpGaD
Conjugated Estrogens—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	4.27e-05	0.000224	CcSEcCtD
Conjugated Estrogens—SLCO1B1—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.26e-05	0.000812	CbGpPWpGaD
Conjugated Estrogens—Insomnia—Doxorubicin—peripheral nervous system neoplasm	4.24e-05	0.000222	CcSEcCtD
Conjugated Estrogens—SLCO1B3—Metabolism—COX2—peripheral nervous system neoplasm	4.23e-05	0.000806	CbGpPWpGaD
Conjugated Estrogens—SLC22A8—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.23e-05	0.000806	CbGpPWpGaD
Conjugated Estrogens—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	4.21e-05	0.000221	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	4.18e-05	0.000219	CcSEcCtD
Conjugated Estrogens—Somnolence—Doxorubicin—peripheral nervous system neoplasm	4.16e-05	0.000219	CcSEcCtD
Conjugated Estrogens—ABCC4—Ectoderm Differentiation—MYC—peripheral nervous system neoplasm	4.15e-05	0.00079	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—SUZ12—peripheral nervous system neoplasm	4.15e-05	0.000789	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.14e-05	0.000789	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—GNS—peripheral nervous system neoplasm	4.14e-05	0.000788	CbGpPWpGaD
Conjugated Estrogens—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	4.14e-05	0.000217	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	4.12e-05	0.000217	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	4.07e-05	0.000214	CcSEcCtD
Conjugated Estrogens—ESR1—Signaling by ERBB4—ERBB2—peripheral nervous system neoplasm	4.06e-05	0.000773	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.06e-05	0.000772	CbGpPWpGaD
Conjugated Estrogens—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	4.04e-05	0.000212	CcSEcCtD
Conjugated Estrogens—Fatigue—Doxorubicin—peripheral nervous system neoplasm	4.04e-05	0.000212	CcSEcCtD
Conjugated Estrogens—Urticaria—Epirubicin—peripheral nervous system neoplasm	4.02e-05	0.000211	CcSEcCtD
Conjugated Estrogens—Constipation—Doxorubicin—peripheral nervous system neoplasm	4.01e-05	0.00021	CcSEcCtD
Conjugated Estrogens—Pain—Doxorubicin—peripheral nervous system neoplasm	4.01e-05	0.00021	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	4e-05	0.00021	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	4e-05	0.00021	CcSEcCtD
Conjugated Estrogens—ESR1—Leptin signaling pathway—HRAS—peripheral nervous system neoplasm	3.98e-05	0.000757	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—NME1—peripheral nervous system neoplasm	3.97e-05	0.000755	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.95e-05	0.000751	CbGpPWpGaD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	3.91e-05	0.000744	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	3.9e-05	0.000742	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—GNS—peripheral nervous system neoplasm	3.87e-05	0.000737	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.85e-05	0.000733	CbGpPWpGaD
Conjugated Estrogens—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	3.83e-05	0.000201	CcSEcCtD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	3.83e-05	0.000728	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—COX2—peripheral nervous system neoplasm	3.82e-05	0.000727	CbGpPWpGaD
Conjugated Estrogens—ABCG2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	3.81e-05	0.000725	CbGpPWpGaD
Conjugated Estrogens—ESR1—Regulation of Telomerase—AKT1—peripheral nervous system neoplasm	3.8e-05	0.000723	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.78e-05	0.000719	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—GNAS—peripheral nervous system neoplasm	3.77e-05	0.000718	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	3.77e-05	0.000717	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.76e-05	0.000715	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—BCHE—peripheral nervous system neoplasm	3.75e-05	0.000714	CbGpPWpGaD
Conjugated Estrogens—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	3.73e-05	0.000196	CcSEcCtD
Conjugated Estrogens—ABCC1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.73e-05	0.00071	CbGpPWpGaD
Conjugated Estrogens—Urticaria—Doxorubicin—peripheral nervous system neoplasm	3.72e-05	0.000195	CcSEcCtD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	3.71e-05	0.000706	CbGpPWpGaD
Conjugated Estrogens—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	3.7e-05	0.000194	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	3.7e-05	0.000194	CcSEcCtD
Conjugated Estrogens—Asthenia—Epirubicin—peripheral nervous system neoplasm	3.63e-05	0.000191	CcSEcCtD
Conjugated Estrogens—SLCO1A2—Metabolism—GNS—peripheral nervous system neoplasm	3.6e-05	0.000686	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—HGF—peripheral nervous system neoplasm	3.59e-05	0.000684	CbGpPWpGaD
Conjugated Estrogens—Pruritus—Epirubicin—peripheral nervous system neoplasm	3.58e-05	0.000188	CcSEcCtD
Conjugated Estrogens—SLC10A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.58e-05	0.000681	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	3.55e-05	0.000676	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.54e-05	0.000674	CbGpPWpGaD
Conjugated Estrogens—SLC22A6—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.53e-05	0.000672	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—TH—peripheral nervous system neoplasm	3.53e-05	0.000671	CbGpPWpGaD
Conjugated Estrogens—ESR1—Leptin signaling pathway—AKT1—peripheral nervous system neoplasm	3.51e-05	0.000669	CbGpPWpGaD
Conjugated Estrogens—COMT—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	3.5e-05	0.000665	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.47e-05	0.000661	CbGpPWpGaD
Conjugated Estrogens—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	3.46e-05	0.000182	CcSEcCtD
Conjugated Estrogens—SLCO1A2—Metabolism—NME1—peripheral nervous system neoplasm	3.46e-05	0.000658	CbGpPWpGaD
Conjugated Estrogens—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	3.45e-05	0.000181	CcSEcCtD
Conjugated Estrogens—ABCC2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.42e-05	0.000651	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.41e-05	0.000649	CbGpPWpGaD
Conjugated Estrogens—SLC22A8—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.41e-05	0.000648	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—ENO2—peripheral nervous system neoplasm	3.4e-05	0.000648	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	3.4e-05	0.000647	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	3.38e-05	0.000644	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.38e-05	0.000644	CbGpPWpGaD
Conjugated Estrogens—Asthenia—Doxorubicin—peripheral nervous system neoplasm	3.36e-05	0.000176	CcSEcCtD
Conjugated Estrogens—Dizziness—Epirubicin—peripheral nervous system neoplasm	3.35e-05	0.000176	CcSEcCtD
Conjugated Estrogens—SLC22A8—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.34e-05	0.000636	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—COX2—peripheral nervous system neoplasm	3.33e-05	0.000633	CbGpPWpGaD
Conjugated Estrogens—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.31e-05	0.000174	CcSEcCtD
Conjugated Estrogens—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—peripheral nervous system neoplasm	3.3e-05	0.000629	CbGpPWpGaD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	3.3e-05	0.000628	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	3.29e-05	0.000627	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.27e-05	0.000621	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	3.25e-05	0.000619	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—GNS—peripheral nervous system neoplasm	3.24e-05	0.000617	CbGpPWpGaD
Conjugated Estrogens—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.22e-05	0.000169	CcSEcCtD
Conjugated Estrogens—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.21e-05	0.000612	CbGpPWpGaD
Conjugated Estrogens—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.21e-05	0.000168	CcSEcCtD
Conjugated Estrogens—ABCC4—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.2e-05	0.00061	CbGpPWpGaD
Conjugated Estrogens—Rash—Epirubicin—peripheral nervous system neoplasm	3.19e-05	0.000168	CcSEcCtD
Conjugated Estrogens—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.19e-05	0.000167	CcSEcCtD
Conjugated Estrogens—Headache—Epirubicin—peripheral nervous system neoplasm	3.17e-05	0.000167	CcSEcCtD
Conjugated Estrogens—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	3.16e-05	0.000602	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.16e-05	0.000601	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—NME1—peripheral nervous system neoplasm	3.11e-05	0.000592	CbGpPWpGaD
Conjugated Estrogens—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.1e-05	0.000163	CcSEcCtD
Conjugated Estrogens—ESR1—Signaling by ERBB4—NRAS—peripheral nervous system neoplasm	3.09e-05	0.000588	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—GNS—peripheral nervous system neoplasm	3.08e-05	0.000587	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	3.07e-05	0.000585	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.04e-05	0.000579	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.02e-05	0.000576	CbGpPWpGaD
Conjugated Estrogens—Nausea—Epirubicin—peripheral nervous system neoplasm	3.01e-05	0.000158	CcSEcCtD
Conjugated Estrogens—ABCC1—Metabolism—COX2—peripheral nervous system neoplasm	2.99e-05	0.00057	CbGpPWpGaD
Conjugated Estrogens—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.98e-05	0.000156	CcSEcCtD
Conjugated Estrogens—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.98e-05	0.000566	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.97e-05	0.000565	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—NME1—peripheral nervous system neoplasm	2.96e-05	0.000563	CbGpPWpGaD
Conjugated Estrogens—Rash—Doxorubicin—peripheral nervous system neoplasm	2.95e-05	0.000155	CcSEcCtD
Conjugated Estrogens—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	2.95e-05	0.000155	CcSEcCtD
Conjugated Estrogens—Headache—Doxorubicin—peripheral nervous system neoplasm	2.93e-05	0.000154	CcSEcCtD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	2.89e-05	0.000551	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—GNAS—peripheral nervous system neoplasm	2.88e-05	0.000548	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—BCHE—peripheral nervous system neoplasm	2.87e-05	0.000547	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	2.85e-05	0.000543	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—COX2—peripheral nervous system neoplasm	2.85e-05	0.000541	CbGpPWpGaD
Conjugated Estrogens—SLC22A6—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.84e-05	0.000541	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.82e-05	0.000538	CbGpPWpGaD
Conjugated Estrogens—SLC22A6—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.79e-05	0.000531	CbGpPWpGaD
Conjugated Estrogens—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.78e-05	0.000146	CcSEcCtD
Conjugated Estrogens—SLCO1B3—Metabolism—ENO2—peripheral nervous system neoplasm	2.78e-05	0.000529	CbGpPWpGaD
Conjugated Estrogens—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.75e-05	0.000524	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.74e-05	0.000522	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	2.74e-05	0.000521	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.72e-05	0.000518	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PPP3R1—peripheral nervous system neoplasm	2.71e-05	0.000516	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—TH—peripheral nervous system neoplasm	2.7e-05	0.000514	CbGpPWpGaD
Conjugated Estrogens—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.7e-05	0.000514	CbGpPWpGaD
Conjugated Estrogens—COMT—Neuronal System—HRAS—peripheral nervous system neoplasm	2.68e-05	0.00051	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.67e-05	0.000508	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	2.63e-05	0.000501	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—PTPN11—peripheral nervous system neoplasm	2.62e-05	0.000499	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.59e-05	0.000492	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.54e-05	0.000483	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.52e-05	0.00048	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—ENO2—peripheral nervous system neoplasm	2.51e-05	0.000477	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	2.49e-05	0.000473	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—NTS—peripheral nervous system neoplasm	2.44e-05	0.000464	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	2.4e-05	0.000457	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.39e-05	0.000456	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	2.38e-05	0.000452	CbGpPWpGaD
Conjugated Estrogens—ESR2—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	2.36e-05	0.00045	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.35e-05	0.000447	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—BCHE—peripheral nervous system neoplasm	2.35e-05	0.000447	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—ENO2—peripheral nervous system neoplasm	2.35e-05	0.000447	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CD55—peripheral nervous system neoplasm	2.34e-05	0.000445	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling by ERBB4—HRAS—peripheral nervous system neoplasm	2.26e-05	0.00043	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.24e-05	0.000426	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—TH—peripheral nervous system neoplasm	2.21e-05	0.00042	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—GNAS—peripheral nervous system neoplasm	2.21e-05	0.00042	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—ENO2—peripheral nervous system neoplasm	2.18e-05	0.000416	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—ABCB1—peripheral nervous system neoplasm	2.17e-05	0.000412	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.13e-05	0.000406	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—BCHE—peripheral nervous system neoplasm	2.12e-05	0.000403	CbGpPWpGaD
Conjugated Estrogens—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	2.06e-05	0.000392	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.02e-05	0.000385	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	2.01e-05	0.000382	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling by ERBB4—AKT1—peripheral nervous system neoplasm	2e-05	0.00038	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—TH—peripheral nervous system neoplasm	1.99e-05	0.000379	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.98e-05	0.000376	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.97e-05	0.000375	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—ENO2—peripheral nervous system neoplasm	1.97e-05	0.000374	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.95e-05	0.000371	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—SLC2A1—peripheral nervous system neoplasm	1.89e-05	0.00036	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—ENO2—peripheral nervous system neoplasm	1.87e-05	0.000355	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.85e-05	0.000352	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.85e-05	0.000351	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—GNAS—peripheral nervous system neoplasm	1.8e-05	0.000343	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.79e-05	0.000341	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.77e-05	0.000337	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.76e-05	0.000335	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—TH—peripheral nervous system neoplasm	1.74e-05	0.00033	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	1.73e-05	0.000329	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.71e-05	0.000325	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.7e-05	0.000324	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.66e-05	0.000317	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—BCHE—peripheral nervous system neoplasm	1.66e-05	0.000316	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—GNAS—peripheral nervous system neoplasm	1.63e-05	0.00031	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.63e-05	0.000309	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.61e-05	0.000306	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.6e-05	0.000304	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.58e-05	0.000302	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—BCHE—peripheral nervous system neoplasm	1.58e-05	0.0003	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—NRAS—peripheral nervous system neoplasm	1.58e-05	0.0003	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—TH—peripheral nervous system neoplasm	1.56e-05	0.000297	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.54e-05	0.000294	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.51e-05	0.000287	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—TH—peripheral nervous system neoplasm	1.48e-05	0.000282	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.48e-05	0.000282	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	1.46e-05	0.000278	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.42e-05	0.000271	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.42e-05	0.00027	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.42e-05	0.00027	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.39e-05	0.000265	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.39e-05	0.000265	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	1.37e-05	0.000261	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.32e-05	0.00025	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.29e-05	0.000246	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.28e-05	0.000244	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—GNAS—peripheral nervous system neoplasm	1.27e-05	0.000243	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.27e-05	0.000242	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.25e-05	0.000238	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	1.23e-05	0.000234	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—GNAS—peripheral nervous system neoplasm	1.21e-05	0.000231	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—TP53—peripheral nervous system neoplasm	1.21e-05	0.000229	CbGpPWpGaD
Conjugated Estrogens—ESR1—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	1.19e-05	0.000227	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.19e-05	0.000226	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	1.18e-05	0.000225	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—HRAS—peripheral nervous system neoplasm	1.15e-05	0.000219	CbGpPWpGaD
Conjugated Estrogens—ESR2—Gene Expression—MYC—peripheral nervous system neoplasm	1.14e-05	0.000217	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	1.14e-05	0.000216	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	1.12e-05	0.000213	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.1e-05	0.000209	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.1e-05	0.000209	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PTPN11—peripheral nervous system neoplasm	1.06e-05	0.000201	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.04e-05	0.000199	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.04e-05	0.000198	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—AKT1—peripheral nervous system neoplasm	1.02e-05	0.000194	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	9.58e-06	0.000182	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	9.51e-06	0.000181	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	9.35e-06	0.000178	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	9.12e-06	0.000173	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	8.8e-06	0.000168	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	8.77e-06	0.000167	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—ERBB2—peripheral nervous system neoplasm	8.36e-06	0.000159	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	7.9e-06	0.00015	CbGpPWpGaD
Conjugated Estrogens—ESR2—Gene Expression—AKT1—peripheral nervous system neoplasm	7.89e-06	0.00015	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—AKT1—peripheral nervous system neoplasm	7.77e-06	0.000148	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.54e-06	0.000143	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	7.46e-06	0.000142	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	7.43e-06	0.000141	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.66e-06	0.000127	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—NRAS—peripheral nervous system neoplasm	6.36e-06	0.000121	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	6.31e-06	0.00012	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	6.06e-06	0.000115	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.02e-06	0.000115	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—AKT1—peripheral nervous system neoplasm	5.96e-06	0.000113	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	5.93e-06	0.000113	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—MYC—peripheral nervous system neoplasm	5.92e-06	0.000113	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	5.76e-06	0.00011	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—MYC—peripheral nervous system neoplasm	5.74e-06	0.000109	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.26e-06	0.0001	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	4.87e-06	9.26e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—AKT1—peripheral nervous system neoplasm	4.87e-06	9.26e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	4.84e-06	9.21e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.78e-06	9.09e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	4.75e-06	9.04e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—HRAS—peripheral nervous system neoplasm	4.65e-06	8.86e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.64e-06	8.84e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	4.58e-06	8.71e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—AKT1—peripheral nervous system neoplasm	4.39e-06	8.36e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—AKT1—peripheral nervous system neoplasm	4.11e-06	7.82e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4e-06	7.62e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—AKT1—peripheral nervous system neoplasm	3.98e-06	7.57e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—AKT1—peripheral nervous system neoplasm	3.82e-06	7.28e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	3.74e-06	7.11e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.73e-06	7.1e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	3.67e-06	6.98e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—AKT1—peripheral nervous system neoplasm	3.44e-06	6.55e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—AKT1—peripheral nervous system neoplasm	3.27e-06	6.22e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.06e-06	5.83e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	3.03e-06	5.76e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.93e-06	5.58e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.59e-06	4.92e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.64e-06	3.12e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.31e-06	2.49e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.01e-06	1.92e-05	CbGpPWpGaD
